High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis.
Kontou-Fili K; Allergy, 2008, vol. 63, issue 3, p 376, ISSN 13989995. ISBN 13989995.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef